1. Home
  2. VOGX vs MBUU Comparison

VOGX vs MBUU Comparison

Compare VOGX & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vogenx Inc Common Stock

VOGX

Vogenx Inc Common Stock

N/A

Current Price

$19.50

Market Cap

482.8M

Sector

Health Care

ML Signal

N/A

Logo Malibu Boats Inc.

MBUU

Malibu Boats Inc.

N/A

Current Price

$24.99

Market Cap

541.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VOGX
MBUU
Founded
2021
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
482.8M
541.4M
IPO Year
2026
2013

Fundamental Metrics

Financial Performance
Metric
VOGX
MBUU
Price
$19.50
$24.99
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $34.13
AVG Volume (30 Days)
70.9K
★ 204.8K
Earning Date
11-19-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.09
Revenue
N/A
★ $914,590,000.00
Revenue This Year
N/A
$21.52
Revenue Next Year
N/A
$7.54
P/E Ratio
★ N/A
$264.39
Revenue Growth
N/A
★ 13.25
52 Week Low
$13.50
$21.16
52 Week High
$38.41
$34.97

Technical Indicators

Market Signals
Indicator
VOGX
MBUU
Relative Strength Index (RSI) 54.01 63.75
Support Level $14.61 $24.27
Resistance Level $22.24 $29.75
Average True Range (ATR) 2.60 0.83
MACD 0.71 0.42
Stochastic Oscillator 79.60 89.81

Price Performance

Historical Comparison
VOGX
MBUU

About VOGX Vogenx Inc Common Stock

Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.

About MBUU Malibu Boats Inc.

Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Most recently, in 2026, it tied up with Saxdor Yachts, focused on adventure dayboats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.

Share on Social Networks: